Good news is Chanticleer not yet predicting insolvency, just a much diminished firm moving forward.
http://www.copyright link/brand/cha...will-be-severely-embarrassing-20160224-gn2x1q
Small extracts from article:
"It would not surprise Chanticleer if Slater & Gordon wrote down the entire $710 million in goodwill acquired in the [Quindell] transaction. That is more than double the company's $292 million market capitalisation.
Irrespective of the size of the goodwill impairment there will be a concurrent question about the value of Professional Services Division's work in progress, which was valued at $420 million at the time of the transaction in April last year.
If goodwill is impaired then it is logical that the business underpinning that must also be doubtful."
and
"Skippen will surely be highly embarrassed about the UK write downs given he blamed the company's problems on hedge funds, short sellers and the media. Egg will stick..."
- Forums
- ASX - By Stock
- SGH
- Chanticleer: "Write downs will be severely embarrassing"
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

Chanticleer: "Write downs will be severely embarrassing"
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
2 | 443 | 51.130 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 350 | 51.000 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 1043 | 5 |
51.520 | 736 | 1 |
51.550 | 487 | 2 |
51.580 | 512 | 1 |
51.590 | 445 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online